Teva Pharmaceutical Industries Limited
NYSE: TEVA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Richard D. Francis
- Employees
- 37,000
- Headquarters
- Tel Aviv, Israel
- IPO year
- 1982
- Market cap
- $36.7B
- Website
- https://www.tevapharm.com
Loading TEVA…
Loading profile data…Frequently asked questions about TEVA
What does Teva Pharmaceutical Industries Limited (TEVA) do?
Teva Pharmaceutical Industries Limited functions as a global pharmaceutical enterprise, involved in the conception, manufacturing, marketing, and provision of a broad spectrum of generic, specialty, and biopharmaceutical products throughout North America, Europe, and various international markets. The company's diverse product range includes ste...
Where does TEVA trade?
Teva Pharmaceutical Industries Limited (TEVA) trades on the New York Stock Exchange.
What sector is TEVA in?
Teva Pharmaceutical Industries Limited (TEVA) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Teva Pharmaceutical Industries Limited?
Richard D. Francis is the chief executive officer of Teva Pharmaceutical Industries Limited (TEVA).
Where is Teva Pharmaceutical Industries Limited headquartered?
Teva Pharmaceutical Industries Limited is headquartered in Israel.
Does TEVA pay a dividend?
Teva Pharmaceutical Industries Limited (TEVA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TEVA go public?
Teva Pharmaceutical Industries Limited (TEVA) completed its initial public offering in 1982.
Is TEVA an ADR?
Yes — TEVA is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Teva Pharmaceutical Industries Limited reporting and dividends follow the underlying issuer.